ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLIN Clinigen Group Plc

925.00
0.00 (0.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 925.00 924.50 925.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Clinigen Share Discussion Threads

Showing 576 to 599 of 1400 messages
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
23/1/2015
11:08
I'm in with 1500 at 492.5p. (It shows as a sell!) Jim Slater said buy under £5, if I remember correctly from the Telegraph.
cafe tabou
23/1/2015
10:13
after a good update its disappointing to see the share price still around here, anyone got any views as to why?
rufio90210
16/1/2015
13:52
Edison update, in case not seen.

"Clinigen has reported a positive trading update that confirms progress is being maintained as expected. Clinigen operates in highly specialised and defensive niches that benefit from the pharmaceutical industry’s greater outsourcing of non-core functions. This, together with the rising regulatory burden and requirement for auditable supply chains, suggests the solid growth will continue. Our valuation is based on a number of parameters and the range is wide at £479-510m (580-618p a share), suggesting our current value of £495m (600p a share) has scope to rise over time."

hTttp://www.edisoninvestmentresearch.com/research/report/clinigen-group1

hutch_pod
15/1/2015
14:11
Video interview with Clinigen CEO Peter George

Peter George, the chief executive of specialty pharmaceuticals group Clinigen (LON:CLIN), tells Proactive Investors he is particularly pleased with the performance of the clinical trials supply business.
George adds that the group is keen to make more acquisitions that will help it grow geographically, especially in the southern hemisphere.

proactivest
15/1/2015
11:32
Agree, i thought the cash increase looked reasonable and can help fund 'product acquisitions and global expansion'.
hutch_pod
15/1/2015
10:43
More cash buys more new products, (hopefully).
cestnous
15/1/2015
09:30
Look like its in line with positive sentiments.

Maybe the net cash doubling is troubling buyers.

rufio90210
15/1/2015
09:15
Anyone know how the results compare against expectations?
nhb001
15/1/2015
08:47
was expecing a morning rise after that update!
rufio90210
09/1/2015
08:38
Yes, I just dug out the tip.
hutch_pod
09/1/2015
06:18
Bought in yesterday morning on this dip. Looks a very solid company. Slater in here too?
gswredland
08/1/2015
11:31
Yeah - interims next month I believe. Amazing ride last year and i think solid fundamentals.
hutch_pod
08/1/2015
11:07
Still well in profit here and no intention of selling atm.
cestnous
08/1/2015
08:53
on support
gucci
07/1/2015
19:03
Bit of a drop today?
rjd1233
07/1/2015
16:38
No idea - a few sales just killed the bid and limited number of new buy orders popped up.
hutch_pod
07/1/2015
16:02
hopefully will bounce here
might be a place to top up

gucci
15/12/2014
14:49
Might be it. Downgraded to hold but price target upped to 530 from 512. I can't see any other broker changes.
hutch_pod
15/12/2014
13:52
Could be. This has dropped further than I expected. Any fundamental reason for that?
nhb001
15/12/2014
13:22
time for a top up?
gucci
07/12/2014
21:44
Retipped in Telegraph by Jim Slater yesterday for his IHT portfolio. (alongside Telford homes, Restore and Redcentric).
hutch_pod
04/12/2014
18:56
I wonder is gsk's failure to sell off its old drugs as a package will create some cherry picking opportunities?
apad

apad
24/11/2014
10:09
24 Nov 2014 Clinigen Group CLIN Oriel Securities Buy 546.50 549.00 650.00 650.00 Reiterates
mike740
13/11/2014
15:50
excellent call, agreed. amazing to spot that. either I wasn't looking or not looking hard enough.
hutch_pod
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older

Your Recent History

Delayed Upgrade Clock